Atlas Trials

Effect of Quetiapine on Negative Symptoms and Cognition

Clinical trial NCT00305422 · COMPLETED

Trial details

NCT number
NCT00305422
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2001-11-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.